Yazar "Zor, Kürşat Ramazan" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim Yok
    Öğe
    Orbital Abscess in the Case of Amblyopia
    (AVES, 2019) Aksoy, Ahmet; Güngör, Özge Özata; Zor, Kürşat Ramazan
    There are some orbital and intracranial complications of acute and chronic inflammation of paranasal sinuses. Some fatal complications can be encountered despite the wide use of antibiotics. Periorbital cellulitis occurs as a result of inflammation of ethmoid sinuses and is mostly seen in childhood. This clinical condition is characterized by swelling, redness, and ocular pain but the vision is unaffected. A 16-year-old boy with amblyopia on the left eyeball was admitted to our outpatient clinic with a complaint of a headache lasting for two days. Medical treatment was started with the diagnosis of acute sinusitis. In the second day of treatment, the patient was admitted to our clinic because of swelling, redness, and pain on the right eyeball and was hospitalized with the diagnosis of right periorbital cellulitis. Despite using two different intravenous antibiotics, the patient’s visual acuity was decreased and his eyeball move-ments’ limitation was increased within hours. The patient did not respond to treatment and therefore subperiosteal orbital abscess was drained surgically. It is important to consider the age and other conditions of a patient to decrease mortality and morbidity when treating a patient with swelling of the eyelids. Sinusitis is a common disease that may cause an orbital abscess, epidural abscess, and intracranial complications. © 2019 by Turkish Rhinologic Society.
  • Küçük Resim Yok
    Öğe
    Prevalence of dry eye in patients using topical antiglaucoma medications
    (2024) Küçük, Erkut; Zor, Kürşat Ramazan; Karataş, Müge Çoban; Biçer, Gamze Yıldırım
    Aim: Topical antiglaucoma drugs may have adverse effects on the ocular surface. In this study, our aim was to report the frequency of dry eye and the use of artificial tear drops in patients diagnosed with glaucoma and using topical antiglaucoma drugs. We also evaluated factors affecting this association. Methods: Based on the medical records, we selected patients admitted to the ophthalmology department between 2020 and 2021 who had been diagnosed with glaucoma. In this study, we included patients who were using topical antiglaucoma medications and were older than 40 years of age. Age, gender, type, and number of glaucoma medications used, dry eye diagnosis, and use of artificial tear drops and/or topical cyclosporine were recorded. Results: We found that 346 (27%) of the 1,274 patients using topical antiglaucoma drugs had dry eyes and were using artificial tear drops. Gender (female) and the number of antiglaucoma medications used were associated with an increased risk of dry eye in these patients, while increasing age was not associated with dry eye. Conclusion: Dry eye is common in patients using topical antiglaucoma medications and should be considered in the treatment of glaucoma.